GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Instituto de Diagnostico SA (XSGO:INDISA) » Definitions » Operating Income

Instituto de Diagnostico (XSGO:INDISA) Operating Income : CLP14,655 Mil (TTM As of Dec. 2024)


View and export this data going back to 1982. Start your Free Trial

What is Instituto de Diagnostico Operating Income?

Instituto de Diagnostico's Operating Income for the three months ended in Dec. 2024 was CLP4,032 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 was CLP14,655 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Instituto de Diagnostico's Operating Income for the three months ended in Dec. 2024 was CLP4,032 Mil. Instituto de Diagnostico's Revenue for the three months ended in Dec. 2024 was CLP61,841 Mil. Therefore, Instituto de Diagnostico's Operating Margin % for the quarter that ended in Dec. 2024 was 6.52%.

Warning Sign:

Instituto de Diagnostico SA operating margin has been in a 5-year decline. The average rate of decline per year is -14.1%.

Instituto de Diagnostico's 5-Year average Growth Rate for Operating Margin % was -14.10% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Instituto de Diagnostico's annualized ROC % for the quarter that ended in Dec. 2024 was 7.13%. Instituto de Diagnostico's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 10.52%.


Instituto de Diagnostico Operating Income Historical Data

The historical data trend for Instituto de Diagnostico's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instituto de Diagnostico Operating Income Chart

Instituto de Diagnostico Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,349.08 22,450.23 12,949.57 4,199.58 14,654.82

Instituto de Diagnostico Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,725.71 2,000.08 4,761.45 3,861.21 4,032.08

Instituto de Diagnostico Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CLP14,655 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instituto de Diagnostico  (XSGO:INDISA) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Instituto de Diagnostico's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=16128.312 * ( 1 - 6.96% )/( (208507.076 + 212380.686)/ 2 )
=15005.7814848/210443.881
=7.13 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=271127.777 - 48160.002 - ( 16582.671 - max(0, 81933.639 - 96394.338+16582.671))
=208507.076

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=272435.941 - 49174.921 - ( 10880.334 - max(0, 83346.707 - 98835.935+10880.334))
=212380.686

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Instituto de Diagnostico's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=16032.988/( ( (149443.251 + max(798.092, 0)) + (148155.642 + max(6555.26, 0)) )/ 2 )
=16032.988/( ( 150241.343 + 154710.902 )/ 2 )
=16032.988/152476.1225
=10.52 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(51670.858 + 3128.966 + 1767.813) - (48160.002 + 0 + 7609.543)
=798.092

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(60213.33 + 2760.223 + 2620.101) - (49174.921 + 0 + 9863.473)
=6555.26

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Instituto de Diagnostico's Operating Margin % for the quarter that ended in Dec. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=4032.078/61841.294
=6.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Instituto de Diagnostico Operating Income Related Terms

Thank you for viewing the detailed overview of Instituto de Diagnostico's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Instituto de Diagnostico Business Description

Traded in Other Exchanges
N/A
Address
Avenida Santa Maria 1810, Providencia, Santiago, CHL
Instituto de Diagnostico SA, through Clinica Indisa, provides medical and healthcare services. It offers clinical services in the areas of general surgery, traumatology, urology, maternity, dialysis, cardiovascular, odontology, gynecology and obstetrics, blood bank facility, maternity facility, critical patient unit, and various other medical-related services and facilities. Along with its subsidiaries, the company operates in the following segments; Hospitalization which generates maximum revenue and corresponds to services provided to patients who are hospitalized and spend days in bed; Outpatient corresponds to services that do not involve occupation of bed days; and Others corresponds to the parking rental and services category maintenance.

Instituto de Diagnostico Headlines

No Headlines